Skip to main content
Language Translation
  Close Menu

LSA Document #25-626 Optometry Board

LSA Document #25-626 Optometry Board

LSA Document LSA #25-626
Subject Matter Amends 852 IAC 1-1.1-4 concerning applicant fees, transcripts, examination and scores; Amends 852 IAC 1-2.1-2 concerning application file; contents; Amends 852 IAC 1-16-2 concerning responsibilities of licensees; Amends 852 IAC 1-16-3 concerning applications for approval of synchronous in person continuing education sponsor; Adds 852 IAC 1-16-3.5 concerning synchronous virtual continuing education; Amends 852 IAC 1-16-4 concerning standards for approval of optometry continuing education hours; Amends 852 IAC 1-16-4.1 concerning standards for approval for optometric legend drug continuing education hours; Amends 852 IAC 1-16-7 concerning Asynchronous continuing education; Amends 852 IAC 1-17-1 concerning application file contents.

Rulemaking Docket

Date

Information

Notices And Dates
Notice of First Comment Period and Proposed Rule Publication 11-05-2025

https://iar.iga.in.gov/register/20251105-IR-852250626FNA

Notice Of First Public Hearing Published 11-05-2025

iar.iga.in.gov/register/20251105-IR-852250626PHA

Regulatory Analysis Published 11-05-2025

iar.iga.in.gov/register/20251105-IR-852250626RAA

Notice of Second Comment Period and Proposed Rule Publication 03-04-2026

https://iar.iga.in.gov/register/20260304-IR-852250626SNA

Notice Of Second Public Hearing Published 03-04-2026

The public hearing previously scheduled for 4/29/2026 has been cancelled.

Public Hearing And Comments
Deadline For Public Comments 04-03-2026

12/5/2025 - Deadline for First Comment Period

04/03/2026 -Deadline for Second Comment Period

Public Hearing Date and Location 12-10-2025

Indiana Government Center South, 402 West Washington Street, Room W064, Indianapolis, Indiana,

virtually at zoomgov.com

Summaries of Written and Oral Public Comments

First Public Comments Section:

Comments from Dr. Sutton

Comments from NBEO

Comments from IOA

Comments from IEDC

Comments from Dr. Lighthizer

Second Public Comments Section:

Comments from NBEO

Comments from Dr. Reichert

Comments from Dr. Stewart